Heart Failure
Videos
-
28 January 2020 -
06 January 2020 -
04 December 2019 -
04 December 2019 -
03 December 2019 -
22 November 2019
Pages
Heart Failure
The prevalence of heart failure (HF) continues to increase over time1 and affects >60 million people each year2.
Therefore, being aware of the latest data in the HF space and different treatment options is important in order to be able to apply findings to clinical practice when making treatment decisions for patients with type 2 diabetes mellitus (T2DM) and cardiovascular disease, especially HF.
This section is supported by a grant from the Boehringer Ingelheim & Eli Lilly and Company Alliance
Content on this section was partly provided by Boehringer Ingelheim. For any follow up questions please contact your local Boehringer Ingelheim representative.
-
This review summarizes the latest developments in our understanding of the role of the innate and adaptive immune systems in the pathogenesis of heart failure and highlights the results of phase III clinical trials of therapies targeting...
Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Nat Rev Cardiol 2020;17:269–85. -
This article provides an approach for primary care physicians to managing peripheral oedema in people known to have heart failure in the community and the article includes a recap of the best available evidence.
Bromage D, Mayhew J, Sado D. BMJ 2020;369:m2099. -
The current pandemic coronavirus SARS-CoV-2 infects a wide age group but predominantly elderly individuals, especially men and those with cardiovascular disease. Recent reports suggest an association with use of renin–angiotensin–aldosterone...
Sama IE, Ravera A, Santema BT, et al. Eur Heart J 2020;41:1810–7. -
The authors carried out a systematic review and meta-analysis of randomised, placebo-controlled, cardiovascular outcome trials of SGLT2i in patients with type 2 diabetes.
Zelniker TA, Wiviott SD, Raz I, et al. Lancet. 2019;393:31–9.
-
07 Sep 2020 -
07 Sep 2020 -
20 Aug 2020 -
20 Mar 2020
Videos
-
20 Mar 2020 -
25 Jun 2020 -
20 Apr 2020 -
14 Apr 2020 -
28 Jan 2020
Pages
Review articles
-
Rosenbaum AN, Agre KE, Pereira NL. Nat Rev Cardiol 2020;17:286–97.
-
Skelin M, Lucijanic M, Javor E. Eur Heart J 2020;41:325.
-
Tanaka A, Node K. Diabetol Int 2020.
-
Packer M. European Heart Journal 2020;41:2393–6.
-
Handelsman Y. Adv Ther 2019;36:2567–86.
Pages
Systematic Analysis
-
Khera R, Wang Y, Bernheim SM, et al. BMJ 2020;368:l6831.
-
Rolnick JA, Liao JM, Emanuel EJ, et al. BMJ 2020;369:m1780.
-
Ghosh-Swaby OR, Goodman SG, Leiter LA, et al. Lancet Diabetes Endocrinol 2020;8:418–35.
-
Vos T, Flaxman AD, Naghavi M, et al. Lancet 2012;380:2163–96.
-
Zelniker TA, Wiviott SD, Raz I, et al. Lancet. 2019;393:31–9.
Pages
Guidelines
-
Ponikowski P, Voors AA, Anker SD, et al. Eur Heart J 2016;37:2129–200.
-
Yancy CW, Jessup M, Bozkurt B, et al. Circulation 2017;136:e137–e161.
-
Yancy CW, Jessup M, Bozkurt B, et al. Circulation 2013;128:e240–e327.
-
Bromage D, Mayhew J, Sado D. BMJ 2020;369:m2099.
Pages
Clinical Case Study
-
Pasternak B, Ueda P, Eliasson B, et al. BMJ 2019;366:l4772.
-
Gunawan F, Partridge C, Kosiborod M, Inzucchi S. Journal of the Endocrine Society 2019;3(Supplement_1):SUN-149.
-
McMurray JJV, DeMets DL, Inzucchi SE, et al. Eur J Heart Fail 2019;21:665–75.
-
Jardine MJ, Mahaffey KW, Neal B, et al. Am J Nephrol 2017;46:462–72.
-
Verma S, Rawat S, Ho KL, et al. JACC Basic Transl Sci 2018;3:575–87.
Pages
Press Announcements
Study Design
Pages
1.Heart disease and stroke statistics-2020 update: a report from the American Heart Association
Virani SS, Alonso A, Benjamin EJ, et al. Circulation 2020;141:e139-e596.
https://doi.org/10.1161/CIR.0000000000000757
2. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Lancet 2017;390:1211-59.
Pages
